N-N-丁基-3-硝基苯甲酰胺 | 70001-47-7

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 中文名称: N-N-丁基-3-硝基苯甲酰胺
• 英文名称: N-butyl-3-nitrobenzamide
• 英文别名: 3-Nitro-N-n-butylbenzamid；BNBA；3-nitro-benzoic acid butylamide；3-Nitro-benzoesaeure-butylamid；N-n-butyl 3-nitrobenzamide；m-nitrobenzoylbutylamide
• CAS: 70001-47-7
• 化学式: C₁₁H₁₄N₂O₃
• mdl: MFCD00458983
• 分子量: 222.244
• InChiKey: PLKPLRMLCSBJKV-UHFFFAOYSA-N

物化性质

• 熔点：
  73-74 °C
• 沸点：
  385.4±25.0 °C(Predicted)
• 密度：
  1.162±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  2.2
• 重原子数：
  16
• 可旋转键数：
  4
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.363
• 拓扑面积：
  74.9
• 氢给体数：
  1
• 氢受体数：
  3

安全信息

• 海关编码：
  2924299090

SDS

Material Safety Data Sheet

---

Section 1. Identification of the substance
N-Butyl-3-nitrobenzamide
Product Name:
Synonyms:

---

Section 2. Hazards identification
Harmful by inhalation, in contact with skin, and if swallowed.
H315: Causes skin irritation
H319: Causes serious eye irritation
H335: May cause respiratory irritation
P261: Avoid breathing dust/fume/gas/mist/vapours/spray
P305+P351+P338: IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses if present
and easy to do – continue rinsing
P302+P352: IF ON SKIN: Wash with soap and water
P321: Specific treatment (see on this label)
P405: Store locked up

---

Section 3. Composition/information on ingredients.
N-Butyl-3-nitrobenzamide
Ingredient name:
CAS number: 70001-47-7

---

Section 4. First aid measures
Immediately wash skin with copious amounts of water for at least 15 minutes while removing
Skin contact:
contaminated clothing and shoes. If irritation persists, seek medical attention.
Eye contact: Immediately wash skin with copious amounts of water for at least 15 minutes. Assure adequate
flushing of the eyes by separating the eyelids with fingers. If irritation persists, seek medical
attention.
Inhalation: Remove to fresh air. In severe cases or if symptoms persist, seek medical attention.
Wash out mouth with copious amounts of water for at least 15 minutes. Seek medical attention.
Ingestion:

---

Section 5. Fire fighting measures
In the event of a fire involving this material, alone or in combination with other materials, use dry
powder or carbon dioxide extinguishers. Protective clothing and self-contained breathing apparatus
should be worn.

---

Section 6. Accidental release measures
Personal precautions: Wear suitable personal protective equipment which performs satisfactorily and meets local/state/national
standards.
Respiratory precaution: Wear approved mask/respirator
Hand precaution: Wear suitable gloves/gauntlets
Skin protection: Wear suitable protective clothing
Eye protection: Wear suitable eye protection
Methods for cleaning up: Mix with sand or similar inert absorbent material, sweep up and keep in a tightly closed container
for disposal. See section 12.
Environmental precautions: Do not allow material to enter drains or water courses.

---

Section 7. Handling and storage
Handling: This product should be handled only by, or under the close supervision of, those properly qualified
in the handling and use of potentially hazardous chemicals, who should take into account the fire,
health and chemical hazard data given on this sheet.
Storage: Store in closed vessels.

---

Section 8. Exposure Controls / Personal protection
Engineering Controls: Use only in a chemical fume hood.
Personal protective equipment: Wear laboratory clothing, chemical-resistant gloves and safety goggles.
General hydiene measures: Wash thoroughly after handling. Wash contaminated clothing before reuse.

---

Section 9. Physical and chemical properties
Not specified
Appearance:
Boiling point: No data
Melting point: No data
Flash point: No data
Density: No data
Molecular formula: C11H14N2O3
Molecular weight: 222.2

---

Section 10. Stability and reactivity
Conditions to avoid: Heat, flames and sparks.
Materials to avoid: Oxidizing agents.
Possible hazardous combustion products: Carbon monoxide, nitrogen oxides.

---

Section 11. Toxicological information
No data.

---

Section 12. Ecological information
No data.

---

Section 13. Disposal consideration
Arrange disposal as special waste, by licensed disposal company, in consultation with local waste
disposal authority, in accordance with national and regional regulations.

---

Section 14. Transportation information
Non-harzardous for air and ground transportation.

---

Section 15. Regulatory information
No chemicals in this material are subject to the reporting requirements of SARA Title III, Section
302, or have known CAS numbers that exceed the threshold reporting levels established by SARA
Title III, Section 313.

---

SECTION 16 - ADDITIONAL INFORMATION
N/A

反应信息

• 作为反应物：
  描述：

  N-N-丁基-3-硝基苯甲酰胺 在 tin(ll) chloride 作用下， 以 乙醇 为溶剂， 生成 3-氨基-N-丁基苯甲酰胺
  参考文献：
  名称：

  3-(2′-Bromopropionylamino)-benzamides as novel S-phase arrest agents

  摘要：

  We report the synthesis, anti proliferative activity, and SAR of novel 3-(2'-bromopropionylamino)-benzamides. Many of the benzamide compounds showed potent cytotoxicities against Molt-3 leukemia cells. Several compounds exihibited cytotoxicities (under 6.5 mu M) against five solid tumor cell lines. The mechanism of action of the most potent benzamide 101 does not involve targeting on tubulin but it causes cell cycle S-phase arrest. This active S-phase arrest agent merits further investigation. (c) 2007 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.bmcl.2007.10.016
• 作为产物：
  描述：

  正丁胺 、 间硝基苯甲酰氯 在 三乙胺 作用下， 以 N,N-二甲基甲酰胺 为溶剂， 生成 N-N-丁基-3-硝基苯甲酰胺
  参考文献：
  名称：

  3-(2′-Bromopropionylamino)-benzamides as novel S-phase arrest agents

  摘要：

  We report the synthesis, anti proliferative activity, and SAR of novel 3-(2'-bromopropionylamino)-benzamides. Many of the benzamide compounds showed potent cytotoxicities against Molt-3 leukemia cells. Several compounds exihibited cytotoxicities (under 6.5 mu M) against five solid tumor cell lines. The mechanism of action of the most potent benzamide 101 does not involve targeting on tubulin but it causes cell cycle S-phase arrest. This active S-phase arrest agent merits further investigation. (c) 2007 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.bmcl.2007.10.016

文献信息

• Aminocarbonylations Employing Mo(CO)₆ and a Bridged Two-Vial System: Allowing the Use of Nitro Group Substituted Aryl Iodides and Aryl Bromides
  作者：Patrik Nordeman、Luke R. Odell、Mats Larhed

  DOI：10.1021/jo302322w

  日期：2012.12.21

  A bridged two-vial system aminocarbonylation protocol where Mo(CO)6 functions as an external in situ solid source of CO has been developed. For the first time both nitro group containing aryl/heteroaryl iodides and bromides gave good to excellent yields in the Mo(CO)6-mediated and palladium(0)-catalyzed conversion to benzamides, while the identical one-vessel protocol afforded extensive reduction of

  已开发了桥接的两瓶系统氨基羰基化方案，其中Mo（CO）6用作外部原位CO固体源。含硝基的芳基/杂芳基碘化物和溴化物都首次在Mo（CO）6介导的和钯（0）催化的转化为苯甲酰胺的过程中获得了优异的优异收率，而相同的单容器实验方案则大大降低了硝基功能。上述桥连的两室方案在65–85°C反应温度下对伯胺和仲胺以及迟钝的苯胺亲核试剂均提供了良好的结果。
• Radical-mediated divergent cyclization of benzamides toward perfluorinated or cyanated isoquinolinediones
  作者：You-Lin Deng、Shi Tang、Guo-Liang Ding、Ming-Wei Wang、Jie Li、Zeng-Zeng Li、Li Yuan、Rui-Long Sheng

  DOI：10.1039/c6ob01550f

  日期：——

  divergent cyclization of benzamides, which leads to perfluorinated or cyanated isoquinolinediones, is developed. In the presence of AIBN, methacryloyl benzamides with perfluoroalkyl iodides undergo cascade radical addition/cyclization to afford perfluoroinated isoquinolinediones as the major product under metal-free conditions, whereas the use of CuI (10 mol%) is able to redirect the cyclization to yield

  开发了一种简单高效的苯甲酰胺铜控制的发散环化反应，该反应可导致全氟或氰化异喹啉二酮。在AIBN存在下，甲基丙烯酰基苯甲酰胺与全氟烷基碘进行级联自由基加成/环化反应，在无金属条件下提供全氟代异喹啉二酮为主要产物，而使用CuI（10 mol％）能够使环化重新定向以生成异喹啉二酮。带有一个α-氰基季碳中心。环化具有可控的发散合成和广泛的底物范围以及高度实用的反应条件，从而使该策略成为氟化或氰酸化异喹啉二酮的极具吸引力的手段。
• Thermosensitive recording material and novel color developer compounds
  申请人：OJI PAPER CO., LTD.

  公开号：EP1264707A3

  公开（公告）日：2004-05-19

  Disclosed is a thermosensitive recording material comprising a sheet-shaped support and a thermosensitive recording layer which is formed on at least one surface of the support and comprises a colorless or light-colored dye precursor and a color developer capable of reacting with the dye precursor and inducing color formation therein upon application of heat thereto, the color developer comprising a compound represented by the following formula (I) or analog thereof::The thermosensitive recording material has high sensitivity and can prevent white background portions from coloring and recorded images from decolorizing in an environmental resistance test.

  本发明揭示了一种热敏记录材料，包括一种片状支撑和一种热敏记录层，该热敏记录层形成在支撑的至少一个表面上，并包括一种无色或浅色染料前体和一种能够与染料前体反应并在施加热量后在其中诱导颜色形成的显色剂，其中显色剂包括由以下化学式(I)或其类似物表示的化合物：该热敏记录材料具有高灵敏度，并且可以防止白色背景部分着色和记录图像在环境抗性测试中褪色。
• [EN] BENZAMIDES FOR NEURODEGENERATIVE DISORDER TREATMENT<br/>[FR] BENZAMIDES DESTINES AU TRAITEMENT DE TROUBLES NEURO-DEGENERATIFS
  申请人：CENTAUR PHARMACEUTICALS, INC.

  公开号：WO1996031462A1

  公开（公告）日：1996-10-10

  (EN) Disclosed are pharmaceutical compositions containing as active ingredient a compound of formula (I) wherein R' is a saturated alkyl of 3 to 5 carbon atoms, each R is independently -NO2 or -NH2 or -NHCOCH3, and n is 1 or 2. Some of these compounds are new. A process for their preparation is also disclosed, as well as their use in the manufacture of medicaments for treating conditions characterised by progressive loss of central nervous system such as Parkinson's disease or Alzheimer's.(FR) Des compositions pharmaceutiques contiennent en guise d'ingrédient actif un composé de formule (I) où R' représente au alkyle saturé doté de 3 à 5 atomes de carbone, R représente indépendemment -NO2, -NH2 ou -NHCOCH3, et n vaut 1 ou 2. Certains de ces composés sont nouveaux. On décrit aussi un procédé permettant de les préparer, ainsi que leur utilisation dans la fabrication de médicaments destinés à traiter des troubles caractérisés par une perte progressive des fonctions du système nerveux central, tels que les maladies de Parkinson ou d'Alzheimer.

  （中文）本发明涉及一种药物组合物，其活性成分为式（I）中的化合物，其中R'是3到5个碳原子的饱和烷基，每个R独立地是-NO2、-NH2或-NHCOCH3，n为1或2。其中一些化合物是新的。本发明还公开了一种制备它们的方法，以及它们在制造用于治疗中枢神经系统逐渐丧失的疾病，如帕金森病或阿尔茨海默病的药物中的应用。
• [EN] BENZAMIDE TREATMENT OF DEMENTIA ASSOCIATED WITH AIDS VIRUS (HIV-1) INFECTION<br/>[FR] TRAITEMENT PAR BENZAMIDES DE LA DEMENCE ASSOCIEE A L'INFECTION PAR LE VIRUS DU SIDA (VIH-1)
  申请人：CENTAUR PHARMACEUTICALS, INC.

  公开号：WO1997038684A1

  公开（公告）日：1997-10-23

  (EN) Benzamide-based compositions are disclosed to have activity as therapeutic and prophylactic agents in the treatment of conditions associated with HIV-1 virus infection, referred to in advanced stages as dementia associated with HIV infection or HIV Dementia.(FR) L'invention concerne des compositions à base de benzamides ayant une activité en tant qu'agents thérapeutiques et prophylactiques dans le traitement des pathologies associées à l'infection par le VIH-1, désignées dans les stades avancés par le terme de démence associée à l'infection par le VIH-1 ou d'encéphalopathie du VIH.

  (中文) 揭示了基于苯甲酰胺的组合物具有治疗和预防HIV-1病毒感染相关病症的活性，这些病症在晚期被称为与HIV感染相关的痴呆或HIV痴呆。